Raymond James Financial Services Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,227	Closed	-$44K	–	3271
2021 Q4	$44K	Buy	+10,227	New	+$44K	﹤0.01%	3177
2021 Q3	–	Sell	-22,840	Closed	-$145K	–	3252
2021 Q2	$145K	Buy	22,840 +5,000	+28%	+$31.7K	﹤0.01%	3078
2021 Q1	$138K	Buy	+17,840	New	+$138K	﹤0.01%	2991